Histogen Inc (HSTO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HSTO Annual Balance Sheets →
Tracking balance sheet results across Histogen Inc to Sep 30 2022 helps illustrate how Sep 30 2023's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent4.57
Cash & Short-term Investments4.00
Accounts receivable0.00
Other Current Assets0.30
Prepaid Expense And Other Assets Current0.58
Total Current Assets5.46
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.36
Restricted Cash Current0.30
Operating Lease Right Of Use Asset0.00
Total Assets5.82
Liabilities
Accounts Payable, Current AC0.39
Accrued Liabilities, Current AC0.94
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.02
Total Current Liabilities1.35
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.07
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent-
Total Liabilities1.41
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock103.12
Retained Earnings / Accumulated Deficit-97.69
Other Equity0.00
Common Stockholder's Equity5.44
Non-controlling interests & other-1.03
Total Stockholder's Equity4.40
Liabilities & Stockholder's Equity5.82
4 historic quarters locked

Sign in to unlock the full Histogen Inc balance sheet history.

About Histogen Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-062115

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.